- cafead   May 03, 2019 at 10:52: PM
via The US Food and Drug Administration (FDA) on Friday released draft guidance for sponsors developing stimulant drugs for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric and adult patients.
article source
article source